. Drugs with short half-lives and drugs that easily absorbed from gastrointestinal tract (GIT) are eliminated quickly from the systemic circulation. For these types of drugs the development of oral sustainedcontrolled release formulations is an attempt to release the drug slowly into the gastrointestinal tract (GIT) and maintain an effective drug concentration in the systemic circulation for a long time (3, 2) . But oral sustained drug delivery formulations show some limitations connected with the gastric emptying time; variable and too rapid gastrointestinal transit could result in incomplete drug release from the device into the absorption window leading to diminished efficacy of the administered dose (4, 2) . Floating drug delivery system is an approach to prolong gastric residence time, thereby targeting site-specific drug release in the upper gastrointestinal tract (GIT) for local or systemic effects (4) . In the present investigation, Salbutamol sulfate was selected as a model for the development of gartroretentive drug delivery system (GRFDDS). Salbutamol sulphate act as an b 2 adrenergic receptor agonist widely used for the treatment of bronchial asthma, chronic bronchitis and emphysema (5) . The drug undergoes extensive first-pass metabolism and thus requires frequent administrations by oral route (6) . Salbutamol sulphate has a site-specific absorption in stomach and upper part of small intestine (7) . Reported oral bioavailability of salbutamol sulphate is ~ 40 %; due to extensive metabolism via intestinal sulphonation, first pass metabolism in liver & also degradation in colon (8) . The metabolism is due to extensive sulphonation in gut as compared to liver. The half life of Salbutamol sulphate is about 4.5 hrs (9) . A gastroretentive drug delivery system may be advantageous over conventional oral dosage forms and inhalers due to its ability to maintain prolonged therapeutic concentrations in the systemic circulation (10) .
MATERIALS AND METHODS

Materials:
The drug Salbutamol sulphate was supplied as a gift sample by Ultra Lab Baddi (Himachal Pradesh). All other reagents and chemicals were of analytical grade.
Preparation of floating tablet of Salbutamol sulphate:
Floating Salbutamol sulphate tablet shall be prepared by using full 3 2 factorial design by varying the ratio of sodium bicarbonate and citric acid which was used as a gas generating agent. All tablets were prepared by wet granulation method. All the polymer and active ingredients were passed through sieve no. 80 separately. Required quantity of Salbutamol sulphate, polymers, gas generating, and diluents were mixed thoroughly in a glass motor pestle and sufficient quantity of binding agent was added slowly to get dough mass. The mass was sieved through no.8 mesh and dried at 50˚C temperature for 1 hrs. The dried granules retained on 35 no. mesh were mixed with 10% fines, 2 % talc and 1% magnesium stearate and the tablet were punched with the help of automatic tablet punching machine with desired hardness, shape and size. The formulation parameters are listed below in table no.1.
A Full 3
2 factorial design were made by varying the ratio of gas generating agent:
ABSTRACT:
The present investigation concerns with the development and evaluation of the floating matrix tablets of Salbutamol Sulphate. Tablets were prepared by wet granulation method. Hydroxypropyl methylcellulose and ethyl cellulose was used as a release retardant material. Sodium bicarbonate and Citric acid was incorporated as a gas-generating agent. The effects of Sodium bicarbonate and citric acid on drug release profile, floating properties and matrix integrity of tablet were investigated. Addition of Citric acid in excess amount results in disintegration of the tablet so the floating tablets are prepared by full 
In-vitro dissolution study:
In vitro drug release studies for the prepared floating tablets of salbutamol sulphate were conducted for a period of 10 hrs with an half of interval USP XXIV type-II (Paddle) dissolution apparatus at 37±0.5 o C at 100 rpm using 900 ml of 0.1N HCl as dissolution medium for first two hrs and similarly for next seven hrs dissolution was conducted with 0.2M Phosphate buffer solution at a predetermined interval of time, 5 ml of sample was withdrawn from the dissolution medium and replaced with fresh medium to maintain the sink condition. After filtration and appropriate dilution, the samples were analyzed for salbutamol sulphate by UV spectrophotometer at 276 nm. Then the release kinetics of the drug salbutamol suphate was studied with the help of percentage cumulative drug release by using the models of release kinetics; such as Zero order release kinetics, First order release kinetics, Higuchi model and KorsmeyerPeppas model. Apparent tablet density of all samples showed below (1.004g/cm3) than of gastric fluid. The density decreased due to this expansion and upward force of CO 2 gas generation. This plays an important role in ensuring the floating capability of the dosage form. To provide good floating behavior in the stomach, the density of the tablets should be less than that of the gastric contents. The drug release data were fitted to models representing zero order (cumulative amount of drug released vs. time), Higuchi's (cumulative percentage of drug released vs. square root of time), and Korsmeyer's equation (log cumulative percentage of drug released vs. time) kinetics to know the release mechanisms. Among all the formulations F8 and F9 showed R 2 value of Higuchi model value nearer to unity as compared to the other formulations. The KorsmeyerPeppas (n) data suggest that all formulation show nonfickian transport. Among those formulations F8 formulation were best fitted with korsmeyer model according to n-value.
RESULT AND DISCUSSION
CONCLUSION:
Gastro retentive floating tablets of Salbutamol sulphate were prepared using two hydrophilic polymer like ethyl cellulose and HPMC by full 3 2 factorial design by changing the ratio of gas generating agent. Nine formulations were prepared. All those formulation showed good acceptable Pharmacotechnical characterstics and able to float within 3 minutes. Formulation like F4, F8 and F9 show higher floation capabilities as well as more steady state drug release profile. On comparative kinetic modeling study (such as Zero order, Higuchi model and Korsmeyer-Peppas model) it was found that all the formulation follow Higuchi model and correlation (R2) values were near to unity. Among those formulation F8 and F9 showed R 2 value of Higuchi model more near as compared to the other formulation. In kormeyer pepas model kinetic study it was found that all formulations follow non-fickian diffusion.
